| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 132,085 | 132,593 | 124,622 | 111,541 | | Cost of Revenue | 68,914 | 66,588 | 62,221 | 51,417 | | | Gross Profit | 63,171 | 66,005 | 62,401 | 60,124 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 43,583 | 43,520 | 38,897 | 38,107 | | Non Recurring | 4,062 |
-
|
-
|
-
| | Others | (2,990) | 1,807 | 1,183 | 1,304 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 18,516 | 20,678 | 22,321 | 20,713 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 39 | 84 | (460) | 558 | | Earnings Before Interest And Taxes | 18,555 | 20,762 | 21,861 | 21,271 | | Interest Expense | 17 | 39 | 59 | 113 | | Income Before Tax | 18,538 | 20,723 | 21,802 | 21,158 | | Income Tax Expense | 5,683 | 6,414 | 6,739 | 6,215 | | Minority Interest | (10,841) |
-
|
-
| (4,089) | | | | Net Income From Continuing Ops | 12,855 | 14,309 | 15,063 | 10,854 | | | Non-recurring Events | | Discontinued Operations | (131) | (80) |
-
| (357) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,883 | 14,229 | 15,063 | 10,497 | | Preferred Stock And Other Adjustments | 7,855 | (3,946) | (3,954) | (5) | | | Net Income Applicable To Common Shares | $9,828 | $10,283 | $11,109 | $10,492 |
|
0.28% Nasdaq 
Income Statement
